These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 19356788

  • 21. Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer.
    Esteller M, Herman JG.
    Oncogene; 2004 Jan 08; 23(1):1-8. PubMed ID: 14712205
    [Abstract] [Full Text] [Related]

  • 22. Loss expression of O6-methylguanine DNA methyltransferase by promoter hypermethylation and its relationship to betel quid chewing in oral squamous cell carcinoma.
    Huang SH, Lee HS, Mar K, Ji DD, Huang MS, Hsia KT.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Jun 08; 109(6):883-9. PubMed ID: 20451846
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Mutation analysis of K-ras and beta-catenin genes related to O6-methylguanin-DNA methyltransferase and mismatch repair protein status in human gallbladder carcinoma.
    Kohya N, Kitajima Y, Kitahara K, Miyazaki K.
    Int J Mol Med; 2003 Jan 08; 11(1):65-9. PubMed ID: 12469220
    [Abstract] [Full Text] [Related]

  • 25. Silencing of O6-methylguanine DNA methyltransferase in the absence of promoter hypermethylation in hepatocellular carcinomas from Australia and South Africa.
    Herath NI, Walsh MD, Kew M, Smith JL, Jass JR, Young J, Leggett BA, Macdonald GA.
    Oncol Rep; 2007 Apr 08; 17(4):817-22. PubMed ID: 17342321
    [Abstract] [Full Text] [Related]

  • 26. Alteration of O6-methylguanine-DNA methyltransferase in colorectal neoplasms in sporadic and familial adenomatous polyposis patients.
    Kim SH, Bae SI, Lee HS, Kim WH.
    Mol Carcinog; 2003 May 08; 37(1):32-8. PubMed ID: 12720298
    [Abstract] [Full Text] [Related]

  • 27. Inactivation of O⁶-methyguanine-DNA methyltransferase by promoter hypermethylation: association of epithelial ovarian carcinogenesis in specific histological types.
    Roh HJ, Suh DS, Choi KU, Yoo HJ, Joo WD, Yoon MS.
    J Obstet Gynaecol Res; 2011 Jul 08; 37(7):851-60. PubMed ID: 21450028
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma.
    Nakamichi I, Tomita Y, Zhang B, Sugiyama H, Kanakura Y, Fukuhara S, Hino M, Kanamaru A, Ogawa H, Aozasa K.
    Ann Hematol; 2007 Aug 08; 86(8):557-64. PubMed ID: 17508213
    [Abstract] [Full Text] [Related]

  • 30. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
    Wu JY, Wang J, Lai JC, Cheng YW, Yeh KT, Wu TC, Chen CY, Lee H.
    Ann Surg Oncol; 2008 Nov 08; 15(11):3272-7. PubMed ID: 18712569
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Low microsatellite instability is associated with poor prognosis in stage C colon cancer.
    Kohonen-Corish MR, Daniel JJ, Chan C, Lin BP, Kwun SY, Dent OF, Dhillon VS, Trent RJ, Chapuis PH, Bokey EL.
    J Clin Oncol; 2005 Apr 01; 23(10):2318-24. PubMed ID: 15800322
    [Abstract] [Full Text] [Related]

  • 33. Aberrant methylation and loss of expression of O-methylguanine-DNA methyltransferase in pulmonary squamous cell carcinoma and adenocarcinoma.
    Furonaka O, Takeshima Y, Awaya H, Kushitani K, Kohno N, Inai K.
    Pathol Int; 2005 Jun 01; 55(6):303-9. PubMed ID: 15943786
    [Abstract] [Full Text] [Related]

  • 34. High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations.
    Jesien-Lewandowicz E, Jesionek-Kupnicka D, Zawlik I, Szybka M, Kulczycka-Wojdala D, Rieske P, Sieruta M, Jaskolski D, Och W, Skowronski W, Sikorska B, Potemski P, Papierz W, Liberski PP, Kordek R.
    Cancer Genet Cytogenet; 2009 Jan 15; 188(2):77-82. PubMed ID: 19100509
    [Abstract] [Full Text] [Related]

  • 35. Hypermethylation of CpG island in O6-methylguanine-DNA methyltransferase gene was associated with K-ras G to A mutation in colorectal tumor.
    Qi J, Zhu YQ, Huang MF, Yang D.
    World J Gastroenterol; 2005 Apr 07; 11(13):2022-5. PubMed ID: 15800999
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Epigenetic silencing of the MGMT gene in cancer.
    Soejima H, Zhao W, Mukai T.
    Biochem Cell Biol; 2005 Aug 07; 83(4):429-37. PubMed ID: 16094446
    [Abstract] [Full Text] [Related]

  • 38. A methylation-specific and SYBR-green-based quantitative polymerase chain reaction technique for O6-methylguanine DNA methyltransferase promoter methylation analysis.
    Hattermann K, Mehdorn HM, Mentlein R, Schultka S, Held-Feindt J.
    Anal Biochem; 2008 Jun 01; 377(1):62-71. PubMed ID: 18384736
    [Abstract] [Full Text] [Related]

  • 39. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
    Bae SI, Lee HS, Kim SH, Kim WH.
    Br J Cancer; 2002 Jun 17; 86(12):1888-92. PubMed ID: 12085181
    [Abstract] [Full Text] [Related]

  • 40. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma.
    Zhang YJ, Chen Y, Ahsan H, Lunn RM, Lee PH, Chen CJ, Santella RM.
    Int J Cancer; 2003 Feb 10; 103(4):440-4. PubMed ID: 12478658
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.